CRISPR Therapeutics

CRSP | NASDAQ | 29 Urmăritori

$39.80

+2.90%

$1.12

Urmărește

Overview Metrics Financials

Fair Price

$92.28

Undervalued by 58.8%

Pentru a afișa prețul corect al unei acțiuni, trebuie să fiți membru Bulios Black.

Profile

CRISPR Therapeutics AG is a Swiss biotechnology company specializing in the development of therapeutics based on the revolutionary CRISPR-Cas9 technology. This technology enables precise and efficient editing of genetic material, opening up new possibilities in treating genetic diseases and other conditions. CRISPR Therapeutics focuses its research on the treatment of various genetic disorders, including beta-thalassemia and muscular dystrophy. The company collaborates with renowned scientific institutions and experts to strengthen its research and develop new therapeutic approaches. CRISPR Therapeutics AG is an innovative player in the biotechnology industry and is committed to bringing revolutionary treatments to patients with genetic diseases. CRISPR Therapeutics AG (CRSP) shares represent an attractive investment opportunity for investors who follow the biotechnology sector and seek an innovative company engaged in treating genetic disorders.

Feed

There are no posts to show right now.

CRISPR Therapeutics

Fair Price

Profile

Feed

Logare în Bulios

Creează-ți profilul pe Bulios

De ce Bulios?